Headline: Eli Lilly Exceeds Q4 Earnings, Revenue Expectations - LLY

[Para 1: The Lead] Eli Lilly and Co. (LLY) exceeded Wall Street earnings and revenue forecasts in the fourth quarter of 2026, reporting a per-share profit of $7.54, surpassing the $6.99 estimate. Revenue of $19.29 billion was also above the $17.87 billion projected by analysts. [Para 2-3: Supporting details & Context] The pharmaceutical giant, based in Indianapolis, Indiana, is projecting full-year earnings between $33.50 and $35 per share, with revenue forecasted between $80 billion and $83 billion. These figures reflect the company's robust performance and strong market presence. Eli Lilly's strategic focus on innovation and market leadership is evident in its financial outperformance, solidifying its position in the pharmaceutical sector.